- Page 1 and 2: Aspects of Mono- and Multiple Domin
- Page 3 and 4: Aspects of Mono- and Multiple Domin
- Page 5: Ter nagedachtenis aan mijn vader Vo
- Page 8 and 9: 4.2.1. Introduction 69 4.2.2. Mater
- Page 10 and 11: SRY sex-determining region of the Y
- Page 13 and 14: 1.1. General introduction Introduct
- Page 15 and 16: Introduction and objectives 15 olog
- Page 17 and 18: Mid 1940’s Initial (unsuccessful)
- Page 19 and 20: tonic growth phase >120 days growth
- Page 21 and 22: Introduction and objectives 21 WHO
- Page 23 and 24: Introduction and objectives 23 sibl
- Page 25: Introduction and objectives 25 This
- Page 30 and 31: Chapter 2 30 regimens should be re-
- Page 32 and 33: Chapter 2 32 Table 2.1 Clinical, en
- Page 34 and 35: Chapter 2 34 Table 2.2 Clinical, en
- Page 36 and 37: Chapter 2 36 FSH (IU/l) Oestradiol
- Page 38 and 39: Chapter 2 38 did not decrease durin
- Page 40 and 41: Chapter 2 40 A negative correlation
- Page 42 and 43: Chapter 2 42 2.2. Relationship betw
- Page 44 and 45: Chapter 2 44 effectively increasing
- Page 46 and 47: Chapter 2 46 Table 2.3 Baseline cha
- Page 48 and 49: Chapter 2 48 comparable to the natu
- Page 50 and 51: Chapter 2 50 follicular phase were
- Page 53 and 54: 3.1. Introduction Mild ovarian stim
- Page 55 and 56: Mild ovarian stimulation 55 subsequ
- Page 57 and 58: Mild ovarian stimulation 57 stage,
- Page 59 and 60: Mild ovarian stimulation 59 retriev
- Page 61 and 62: Number of patients ( ) total pregna
- Page 63 and 64: Mild ovarian stimulation 63 B and C
- Page 65 and 66: Mild ovarian stimulation 65 with a
- Page 67: Chapter 4 Alternative approaches to
- Page 70 and 71: Chapter 4 70 et al., 2004b) failed
- Page 72 and 73: Chapter 4 72 most suitable outcome
- Page 74 and 75: Chapter 4 74 Intervention protocols
- Page 76 and 77:
Chapter 4 76 LH (IU/l) FSH (IU/l) 3
- Page 78 and 79:
Chapter 4 78 In case LH is sufficie
- Page 80 and 81:
Chapter 4 80 Papunen et al., 1998;
- Page 82 and 83:
Chapter 4 82 Second phase: In all p
- Page 84 and 85:
Chapter 4 84 Table 4.3 Initial char
- Page 86 and 87:
Chapter 4 86 4.3.4. Discussion The
- Page 89:
Chapter 5 General discussion and co
- Page 92 and 93:
Chapter 5 92 By administration of e
- Page 94 and 95:
Chapter 5 94 concomitant with a hig
- Page 96 and 97:
Chapter 5 96 reduce the negative im
- Page 98 and 99:
Chapter 5 98 no place for GnRH anal
- Page 101 and 102:
References References 101 Aboulghar
- Page 103 and 104:
References 103 de Boer EJ, den Tonk
- Page 105 and 106:
References 105 Fauser BC, Donderwin
- Page 107 and 108:
References 107 Harada T, Yoshida S,
- Page 109 and 110:
References 109 Laufer N, DeCherney
- Page 111 and 112:
References 111 Munne S. (2003) Prei
- Page 113 and 114:
References 113 Schipper I, Hop WC,
- Page 115 and 116:
References 115 van Hooff MH, van de
- Page 117:
Summary / Samenvatting
- Page 120 and 121:
Summary 120 with exogenous FSH. Sub
- Page 122 and 123:
Summary 122 re-establish normal fol
- Page 124 and 125:
Samenvatting 124 ontwikkelende foll
- Page 126 and 127:
Samenvatting 126 E 2 spiegels werde
- Page 129 and 130:
Publications and presentations Publ
- Page 131:
Dankwoord
- Page 134 and 135:
Dankwoord 134 kijk op de afronding
- Page 136 and 137:
Dankwoord 136 Nu de “jus” van h
- Page 138 and 139:
Dankwoord 138 Als laatste mijn vrie
- Page 141:
Curriculum vitae auctoris